glp 1 agonist vs metformin Synergistic effects of with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway The dual impact of GLP-1

They also offer the

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

This article looks at the unwanted side effects of glucagon-like peptide-1 (GLP-1) receptor agonists

are the major companies operating in this market.

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.